Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4 » Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events
Please verify you are not a robot.